8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0000950123-09-003574
Restatement
- Item 4.02 Non-reliance on previously issued financial statements
From the SEC's structured data for this filing
Loading y01218e8vk.htm…